| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8485413 | Vaccine | 2018 | 10 Pages |
Abstract
S. sonnei vaccine candidates WRSs2 and WRSs3 are safe and immunogenic over a wide dose range. Future steps will be to select the most promising candidate and move to human challenge models for efficacy of the vaccine.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Robert W Jr., Shahida Baqar, William Alexander, Michelle Dickey, Monica McNeal, Jill El-Khorazaty, Holly Baughman, Amy Hoeper, Shoshana Barnoy, Akamol E. Suvarnapunya, Robert W. Kaminski, Malabi M. Venkatesan,